Faculty of Medicine and Health Sciences, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium; Department of Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium; AZ Jan Palfijn Gent, Department of Immunology and Allergology, Ghent, Belgium.
Faculty of Medicine and Health Sciences, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium; Department of Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium.
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3051-3059.e1. doi: 10.1016/j.jaip.2021.03.050. Epub 2021 Apr 20.
Perioperative hypersensitivity (POH) reactions constitute a significant clinical and diagnostic challenge. A transient increase in serum tryptase during POH reflects mast cell activation (MCA) and helps to recognize an underlying hypersensitivity mechanism.
To determine the diagnostic performance of different tryptase decision thresholds based on single and paired measurements to document MCA in suspected POH.
Acute serum tryptase (aST) and baseline serum tryptase (bST) samples were obtained from patients referred to our outpatients clinic because of clinical POH. Tryptase samples from controls were obtained before induction (Tt) and 1.5 hours after induction (Tt) in uneventful anesthesia. Different cutoff points for tryptase increase over bST and the percentage increase in tryptase (%T) were calculated and compared with existing thresholds: aST > [1.2 × (bST) + 2] (consensus formula), aST higher than 11.4 ng/mL, and aST higher than 14 ng/mL.
Patients with POH had higher bST and aST levels compared with controls (respectively 5.15 vs 2.28 ng/mL for bST and 20.30 vs 1.92 ng/mL for aST). The consensus formula and a tryptase increase over bST of greater than or equal to 3.2 ng/mL held the highest accuracies to document MCA in POH (respectively 81% and 82%). A bST of higher than 8 ng/mL was present in 4% of controls, 5% of patients with grade 1 POH, 24% of patients with grade 2 POH, 15% of patients with grade 3 POH, and 17% of patients with grade 4 POH.
Our data endorse the consensus formula for detection of MCA in POH. Furthermore, it shows that a bST of higher than 8 ng/mL was associated with occurrence of anaphylaxis.
围手术期过敏反应(POH)构成了重大的临床和诊断挑战。POH 期间血清类胰蛋白酶的短暂增加反映了肥大细胞激活(MCA),有助于识别潜在的过敏机制。
确定基于单次和配对测量的不同类胰蛋白酶决策阈值来记录疑似 POH 中 MCA 的诊断性能。
从因临床 POH 而被转介至我们门诊诊所的患者中获得急性血清类胰蛋白酶(aST)和基线血清类胰蛋白酶(bST)样本。无事件麻醉中,从对照组获得诱导前(Tt)和 1.5 小时后(Tt)的类胰蛋白酶样本。计算并比较了类胰蛋白酶相对于 bST 的增加和类胰蛋白酶增加百分比(%T)的不同截断值与现有阈值:aST> [1.2×(bST)+ 2](共识公式)、aST 高于 11.4ng/mL 和 aST 高于 14ng/mL。
与对照组相比,POH 患者的 bST 和 aST 水平更高(分别为 bST 为 5.15ng/mL 和 aST 为 20.30ng/mL)。共识公式和类胰蛋白酶相对于 bST 的增加大于或等于 3.2ng/mL 具有记录 POH 中 MCA 的最高准确性(分别为 81%和 82%)。在 4%的对照组、5%的 1 级 POH 患者、24%的 2 级 POH 患者、15%的 3 级 POH 患者和 17%的 4 级 POH 患者中存在 bST 高于 8ng/mL。
我们的数据支持共识公式用于检测 POH 中的 MCA。此外,它表明 bST 高于 8ng/mL 与过敏反应的发生有关。